The beneficial role of sitagliptin on endothelial dysfunction and inflammatory processes may be attributable to the elevation of the level of Glucagon-like peptide-1 (GLP-1) that inhibits inflammation in blood vessels. This evidence concerns the gene GCG and endothelial dysfunction.